Gujarat Themis Biosyn P/B Ratio
Gujarat Themis Biosyn (GUJTHEM) P/B ratio is 14.72 (High), book value per share ₹225.45 vs Healthcare average P/B of -0.94 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see GUJTHEM share price.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
GUJTHEM P/B Ratio — Valuation Insights & Book Value Analysis
Gujarat Themis Biosyn price-to-book ratio interpretation, valuation status and historical context — current P/B 14.72 (High). View GUJTHEM 52-week high low for the annual high/low range and current price position.
- Stock appears overvalued with PB of 14.72, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1326.4% above historical average
- Trading at premium to sector average PB of -0.94
Gujarat Themis Biosyn P/B Ratio Historical Trend
GUJTHEM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with Gujarat Themis Biosyn value estimation to assess whether the stock is under or overvalued.
GUJTHEM Historical P/B Ratio — Book Value Per Share & Year-End Price
Gujarat Themis Biosyn annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.96 | ₹225.45 | ₹441.65 | ₹248 | Moderate |
| 2024 | 1.06 | ₹287.14 | ₹305.45 | ₹201 | Moderate |
| 2023 | 0.8 | ₹212.86 | ₹171.05 | ₹149 | Low |
| 2022 | 0.7 | ₹147.14 | ₹103.15 | ₹103 | Low |
| 2021 | 0.64 | ₹100.0 | ₹63.55 | ₹70 | Low |
GUJTHEM vs Healthcare Peers — P/B Ratio Comparison
Gujarat Themis Biosyn P/B 14.72 vs Healthcare average -0.94, median 0.6 — range -31.21–1.0.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |